Story updated at 9:45 a.m.to reflect market activity.
Shares of Marsh & McLennan gained 0.3% to $49.70 in morning trading.
The firm maintained its "buy" rating for the stock. The pirce target increase is due to increased cash flow for the insurance company. UBS analysts also see substantial room for share repurchases and M&A.
Must Read: Warren Buffett's 10 Favorite Dividend Stocks
TheStreet Ratings team rates MARSH & MCLENNAN COS as a Buy with a ratings score of B+. TheStreet Ratings Team has this to say about their recommendation:
"We rate MARSH & MCLENNAN COS (MMC) a BUY. This is driven by several positive factors, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, good cash flow from operations, solid stock price performance and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value."
Highlights from the analysis by TheStreet Ratings Team goes as follows: